Articles from BIOTECH Patent News (July 1, 2003)

1-31 out of 31 article(s)

Title	Type	Words
Accelr8 announces patent filing for rapid DNA and protein.		398
ActivBiotics announces patent issuances covering bacterial infection treatments.		339
Agouron obtains United States patent.	Brief Article	110
Aventis begins shipping influenza vaccine to providers.		547
Cardiome obtains additional oxypurinol patent.		723
CuraGen develops of predictive drug development assay.		469
Department of Health and Human Services obtains United States patent.	Brief Article	113
du Pont obtains United States patent.	Brief Article	74
Emory University obtains United States patent.	Brief Article	64
GenVec receives United States patent for oncology product.	Brief Article	227
ISIS obtains United States patent.	Brief Article	85
Kabushiki Kaisha obtains United States patent.	Brief Article	75
Korea Kumho Petrochemical obtains United States patent.	Brief Article	78
Merck obtains United States patent.	Brief Article	83
Montana State University obtains United States patent.	Brief Article	69
Mount Sinai School of Medicine obtains United States patent.	Brief Article	69
Nucleic acid conference to address intellectual property issues.	Brief Article	217
Oncolytics Biotech granted Ras targeted adenovirus patent.	Brief Article	282
Pharmacopeia achieves research milestone in Celgene collaboration.		289
Pheromone Sciences issued United States patent on sensing and reporting technology.		335
Prima obtains Fc receptor patent.		488
SemBioSys Genetics receives eleventh and twelfth United States patents.		460
SRU Biosystems denies optical patent infringement claim.		246
Suntory obtains United States patent.	Brief Article	70
Svanborg, et al. obtains United States patent.	Brief Article	85
SYN X acquires non-exclusive rights from Roche Diagnostics to NT-proBNP.		920
Targeted Genetics receives patent for enhanced core.		432
Universidade Federal de Minas Gerais obtains United States patent.	Brief Article	89
University of California obtains United States patent.	Brief Article	98
Valentis announces settlement of PEG-liposome patent infringement.	Brief Article	287
XOMA obtains United States patent.	Brief Article	30